From breakthrough science to a scalable company.
We co-build ventures alongside founders and partners, structured AI-First from day zero, with equity participation alongside build mandates.
Five stages, one operating model.
01.
Opportunity & Application Field.
We identify where the technology has the strongest commercial fit using our Application Field Matrix. Most early-stage ventures lose months pursuing the wrong application; we shortcut that with structured evidence.
02.
Commercial Validation.
Before product investment, we validate whether someone will pay, why, and how much. The Commercial Validation Matrix structures hypothesis-driven validation across customer, problem, and willingness-to-pay.
03.
Business Model & Setup.
We design the business model, the legal entity structure, IP arrangements, and the operating model. AI-First from day zero, so no manual debt accumulates.
04.
Team & Initial Capital.
We structure the founding team, define ownership and roles, and prepare the company for the first round of strategic capital.
05.
Operational Launch & Handoff.
We stay operationally involved through launch, then transition into a board or strategic advisor role as the company stands on its own.
Founders.
Scientific or operational founders building deep tech ventures in health and life sciences who want a partner with skin in the game.
Research institutions.
Universities, research clinics, and tech transfer offices structuring spin-offs that need operational co-builders, not just advisory.
Global health companies.
Established pharma, MedTech, or diagnostics organizations spinning up new ventures or corporate spin-outs.
Frameworks We Deploy
Frameworks we deploy in Build.
In Build, the framework family operates continuously. Four frameworks form the operating spine of every venture we co-build.
01
VRL
The shared readiness scale across every workstream and weekly review.
02
CVC
Continuous commercial validation, from first design partner to repeatable sales motion.
03
SVC
Evidence design for clinical, regulatory and payer milestones.
04
AFM
Re-applied at every major pivot to keep application focus disciplined.
CO-BUILD
Clinical innovation venture out of a leading German research hospital. Preventive care focus.
CO-BUILD
Diagnostics venture in development with a senior industry partner. Currently in commercial validation.
CO-BUILD
Consumer health venture in the longevity supplements category. MVP stage.
Specific names and venture details are released selectively, in alignment with our partners.
Every venture we co-build is AI-First from day zero. Process architectures, data flows, and decision logs are designed to be AI-ready from the beginning, so the venture never has to unwind the manual debt that older companies carry. Where AI does not add measurable value, we do not force it. Read our full AI-First approach →